Rights and permissions
About this article
Cite this article
Eli Lilly and Company to fund DM programme in the US. Pharmacoecon. Outcomes News 373, 7 (2002). https://doi.org/10.1007/BF03279384
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279384